Insider Transactions in Q1 2022 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
475
-0.52%
|
$10,450
$22.24 P/Share
|
|
Mar 29
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
830
-0.25%
|
$18,260
$22.24 P/Share
|
|
Mar 29
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
547
-0.64%
|
$12,034
$22.24 P/Share
|
|
Mar 29
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
658
-0.29%
|
$14,476
$22.24 P/Share
|
|
Mar 22
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
551
-1.23%
|
$12,673
$23.06 P/Share
|
|
Mar 09
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,000
-2.96%
|
$230,000
$23.81 P/Share
|
|
Mar 09
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.87%
|
$10,000
$1.9 P/Share
|
|
Mar 07
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,000
-2.96%
|
$230,000
$23.8 P/Share
|
|
Mar 07
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.87%
|
$10,000
$1.9 P/Share
|
|
Mar 01
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
56
-0.26%
|
$1,288
$23.78 P/Share
|
|
Mar 01
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
221
-0.32%
|
$5,083
$23.78 P/Share
|
|
Mar 01
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
874
-0.34%
|
$20,102
$23.78 P/Share
|
|
Mar 01
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
412
-0.2%
|
$9,476
$23.78 P/Share
|
|
Feb 24
2022
|
Marcus Schulz Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,019
+24.92%
|
-
|
|
Feb 24
2022
|
Sarah Aebersold Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,019
+29.78%
|
-
|
|
Feb 24
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,029
+8.49%
|
-
|
|
Feb 24
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
70,094
+17.57%
|
-
|
|
Feb 24
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,365
+16.86%
|
-
|
|
Feb 24
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,356
+16.0%
|
-
|
|
Feb 24
2022
|
Todd Berard Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,019
+13.36%
|
-
|
|
Feb 24
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,365
+34.3%
|
-
|
|
Feb 15
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
695
-3.15%
|
$18,070
$26.57 P/Share
|
|
Feb 10
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
450
-0.22%
|
$13,050
$29.38 P/Share
|
|
Feb 10
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
690
-0.27%
|
$20,010
$29.38 P/Share
|
|
Feb 10
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
293
-0.42%
|
$8,497
$29.38 P/Share
|
|
Feb 10
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
197
-1.02%
|
$5,713
$29.38 P/Share
|
|
Feb 10
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
254
-0.33%
|
$7,366
$29.38 P/Share
|
|
Feb 10
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
167
-0.59%
|
$4,843
$29.38 P/Share
|
|
Feb 03
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,670
-6.04%
|
$450,090
$27.84 P/Share
|
|
Feb 03
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,670
+5.69%
|
$16,670
$1.78 P/Share
|
|
Feb 03
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,837
-4.56%
|
$265,599
$27.76 P/Share
|
|
Feb 03
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,837
+4.36%
|
$19,674
$2.06 P/Share
|
|
Feb 02
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.63%
|
$290,000
$29.88 P/Share
|
|
Feb 02
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.42%
|
$30,000
$3.7 P/Share
|
|
Feb 01
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.04%
|
$483,314
$29.9 P/Share
|
|
Feb 01
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.69%
|
$16,666
$1.78 P/Share
|
|
Jan 20
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
395
-1.37%
|
$11,850
$30.24 P/Share
|
|
Jan 20
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
332
-1.7%
|
$9,960
$30.24 P/Share
|
|
Jan 12
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
267
-0.92%
|
$8,544
$32.18 P/Share
|
|
Jan 12
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.04%
|
$516,646
$31.72 P/Share
|
|
Jan 12
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.69%
|
$16,666
$1.78 P/Share
|
|
Jan 10
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.04%
|
$499,980
$30.83 P/Share
|
|
Jan 10
2022
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.69%
|
$16,666
$1.78 P/Share
|
|
Jan 07
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Open market or private sale
|
Direct |
47
+0.21%
|
$1,410
$30.75 P/Share
|
|
Jan 07
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,816
-3.59%
|
$324,480
$30.75 P/Share
|
|
Jan 05
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,857
-3.67%
|
$267,138
$34.3 P/Share
|
|
Jan 05
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,857
+3.54%
|
$7,857
$1.4 P/Share
|
|
Jan 04
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.63%
|
$350,000
$35.06 P/Share
|
|
Jan 04
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.42%
|
$10,000
$1.4 P/Share
|